Meta-analysis of modifiable risk factors for Alzheimer's disease
Top Cited Papers
- 20 August 2015
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 86 (12), 1299-1306
- https://doi.org/10.1136/jnnp-2015-310548
Abstract
Background The aetiology of Alzheimer's disease (AD) is believed to involve environmental exposure and genetic susceptibility. The aim of our present systematic review and meta-analysis was to roundly evaluate the association between AD and its modifiable risk factors. Methods We systematically searched PubMed and the Cochrane Database of Systematic Reviews from inception to July 2014, and the references of retrieved relevant articles. We included prospective cohort studies and retrospective case–control studies. Results 16 906 articles were identified of which 323 with 93 factors met the inclusion criteria for meta-analysis. Among factors with relatively strong evidence (pooled population >5000) in our meta-analysis, we found grade I evidence for 4 medical exposures (oestrogen, statin, antihypertensive medications and non-steroidal anti-inflammatory drugs therapy) as well as 4 dietary exposures (folate, vitamin E/C and coffee) as protective factors of AD. We found grade I evidence showing that one biochemical exposure (hyperhomocysteine) and one psychological condition (depression) significantly increase risk of developing AD. We also found grade I evidence indicative of complex roles of pre-existing disease (frailty, carotid atherosclerosis, hypertension, low diastolic blood pressure, type 2 diabetes mellitus (Asian population) increasing risk whereas history of arthritis, heart disease, metabolic syndrome and cancer decreasing risk) and lifestyle (low education, high body mass index (BMI) in mid-life and low BMI increasing the risk whereas cognitive activity, current smoking (Western population), light-to-moderate drinking, stress, high BMI in late-life decreasing the risk) in influencing AD risk. We identified no evidence suggestive of significant association with occupational exposures. Conclusions Effective interventions in diet, medications, biochemical exposures, psychological condition, pre-existing disease and lifestyle may decrease new incidence of AD.This publication has 17 references indexed in Scilit:
- Aluminum and its potential contribution to Alzheimer's disease (AD)Frontiers in Aging Neuroscience, 2014
- Smoking Prevalence and Cigarette Consumption in 187 Countries, 1980-2012Jama-Journal Of The American Medical Association, 2014
- Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apartThe Lancet, 2013
- A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and IIThe Lancet, 2013
- The projected effect of risk factor reduction on Alzheimer's disease prevalenceThe Lancet Neurology, 2011
- Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directionsFuture Neurology, 2010
- Peripheral Aβ subspecies as risk biomarkers of Alzheimer's diseaseProceedings of the National Academy of Sciences of the United States of America, 2008
- Global burden of obesity in 2005 and projections to 2030International Journal of Obesity, 2008
- Arterial Stiffness, Cognitive Decline, and Risk of DementiaStroke, 2007
- Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging studyAnnals of Neurology, 2002